Weihai Dynabio Biomed Technology Co, Ltd. – Trademark Portfolio

Entity Type: 99

Weihai Dynabio Biomed Technology Co, Ltd. has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 3 Nice Classification classes, led by Class 32 (Light Beverages) and Class 5 (Pharmaceuticals). This trademark owner is based in Shandong Province.

Shiling Road, Chucun Town, Ind. Dev Zone

No. 90-5

Shandong Province 264200 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UENIX
UENIX
Abandoned 2023
UENIX
UENIX
Abandoned 2023
UENIX
UENIX
Abandoned 2023

Trademark Classifications

Weihai Dynabio Biomed Technology Co, Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Weihai Dynabio Biomed Technology Co, Ltd. have?

Weihai Dynabio Biomed Technology Co, Ltd. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Weihai Dynabio Biomed Technology Co, Ltd. file in?

Weihai Dynabio Biomed Technology Co, Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What is Weihai Dynabio Biomed Technology Co, Ltd.'s trademark registration success rate?

Weihai Dynabio Biomed Technology Co, Ltd. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.